Mandatory notification of trade

29. Aug 2023 | 1 min read

Moss, 29 August 2023

Gentian Diagnostics ASA has today been notified that primary insider Njaal Kind (CFO) on 29 August 2023 purchased 5,000 shares at an average price of 43,40 per share. After the transaction Mr. Kind holds 26,125 shares and 140,670 options in Gentian Diagnostics ASA.

This information is subject to the disclosure requirements in the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.

To see the announcement follow this link: https://newsweb.oslobors.no/message/598195

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..